MedTrace Logo

Impact of Vitamin D Level and Supplement on SLE Patients During COVID-19 Pandemic

NCT04709744 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 38

Last updated 2021-01-15

No results posted yet for this study

Summary

Aim of the work Impact of serum vit D level in SLE patients with COVID-19 disease on severity of infection, duration of COVID-19 disease course, fatigue development as a complication for both SLE and COVID-19 and assess impact of prior chloroquine on COVID-19 disease outcomes Patients and methods 38 SLE patients previously diagnosed and on different lines of lupus management. Participants were presented to chest outpatient clinic and emergency hospital, Mansoura University with manifestation suggesting COVID-19 infection. Serum vit D was measured in serum by ELISA.

Conditions

  • Covid19

Interventions

DRUG

Vitamin D

Impact of serum vit D level in SLE patients with COVID-19 disease on severity of infection, duration of COVID-19 disease course, fatigue development as a complication for both SLE and COVID-19 and assess impact of prior chloroquine on COVID-19 disease outcomes

DIAGNOSTIC_TEST

ELISA

Measure vitamin D level

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • yasmin ElbaiomyAdel, MD · Mansoura University Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2020-12-25
Completion
2020-12-30
FDA Drug
Yes
FDA Device
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04709744 on ClinicalTrials.gov